Innophos Holdings, Inc. Expected to Post Q1 2018 Earnings of $0.65 Per Share (IPHS)

Innophos Holdings, Inc. (NASDAQ:IPHS) – Analysts at KeyCorp issued their Q1 2018 earnings per share (EPS) estimates for Innophos in a note issued to investors on Tuesday. KeyCorp analyst M. Sison expects that the specialty chemicals company will post earnings per share of $0.65 for the quarter. KeyCorp currently has a “Hold” rating on the stock. KeyCorp also issued estimates for Innophos’ Q2 2018 earnings at $0.67 EPS, Q3 2018 earnings at $0.80 EPS and Q4 2018 earnings at $0.63 EPS.

Innophos (NASDAQ:IPHS) last posted its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.06. The firm had revenue of $184.00 million for the quarter, compared to analysts’ expectations of $179.33 million. Innophos had a net margin of 6.19% and a return on equity of 13.90%. The firm’s quarterly revenue was down 1.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.69 earnings per share.

Several other research firms have also recently issued reports on IPHS. Zacks Investment Research cut shares of Innophos from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 4th. BidaskClub raised shares of Innophos from a “hold” rating to a “buy” rating in a report on Friday, December 22nd.

Innophos (NASDAQ:IPHS) traded down $0.79 on Thursday, reaching $46.13. 93,400 shares of the company traded hands, compared to its average volume of 100,500. The firm has a market capitalization of $916.30, a PE ratio of 21.26 and a beta of 0.85. The company has a quick ratio of 1.49, a current ratio of 2.86 and a debt-to-equity ratio of 0.83. Innophos has a 1 year low of $41.66 and a 1 year high of $58.22.

Hedge funds have recently added to or reduced their stakes in the business. Personal Capital Advisors Corp increased its stake in Innophos by 2.7% during the third quarter. Personal Capital Advisors Corp now owns 60,902 shares of the specialty chemicals company’s stock valued at $2,996,000 after purchasing an additional 1,603 shares during the last quarter. Prudential Financial Inc. increased its stake in Innophos by 28.9% during the third quarter. Prudential Financial Inc. now owns 221,651 shares of the specialty chemicals company’s stock valued at $10,903,000 after purchasing an additional 49,630 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Innophos by 0.4% during the second quarter. Dimensional Fund Advisors LP now owns 973,461 shares of the specialty chemicals company’s stock valued at $42,676,000 after purchasing an additional 3,717 shares during the last quarter. Allianz Asset Management GmbH increased its stake in Innophos by 5.4% during the third quarter. Allianz Asset Management GmbH now owns 588,910 shares of the specialty chemicals company’s stock valued at $28,968,000 after purchasing an additional 30,320 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in Innophos by 2.9% during the second quarter. Vanguard Group Inc. now owns 1,926,577 shares of the specialty chemicals company’s stock valued at $84,460,000 after purchasing an additional 54,505 shares during the last quarter. Hedge funds and other institutional investors own 94.46% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Innophos Holdings, Inc. Expected to Post Q1 2018 Earnings of $0.65 Per Share (IPHS)” was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/19/innophos-holdings-inc-expected-to-post-q1-2018-earnings-of-0-65-per-share-iphs.html.

About Innophos

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply